MedTrace Logo

House Calls and Decision Support: Improving Access to Live Donor Transplantation

NCT01786525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2020-07-15

No results posted yet for this study

Summary

The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase access to and reduce disparities - racial, economic, gender - in live donor kidney transplantation (LDKT). Specifically, we expand the research and intensity of an innovative House Calls intervention developed by the principal investigator by including other minorities and socioeconomically disadvantaged patients and by adding a novel Patient-Centered Decision Support component. The main study hypothesis is that participants receiving the novel intervention (House Calls + Patient-Centered Decision Support) will have a higher proportion of LDKT's by the 2-year study endpoint.

Conditions

Interventions

BEHAVIORAL

House Calls

60-minute home based educational intervention which will be administered by a health educator

BEHAVIORAL

Web-Based Patient-Centered Decision Support Intervention

Patients will be provided with access to the study website which will allow them to learn and receive LDKT support in a way the best meets their personal values and preferences

Sponsors & Collaborators

Principal Investigators

  • James R Rodrigue, PhD · Beth Israel Deaconess Medical Center

  • Didier Mandelbrot, MD · Beth Israel Deaconess Medical Center

  • Martha Pavlakis, MS · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2019-05-31
Completion
2020-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786525 on ClinicalTrials.gov